Combination pharmacotherapy: A mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats
Ah. Rezvani et al., Combination pharmacotherapy: A mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats, ALC ALCOHOL, 35(1), 2000, pp. 76-83
It is common to treat some diseases with more than one medication simultane
ously Since more than one neurotransmitter system is involved in alcohol-se
eking behaviour, then a therapeutic approach that targets more than one sys
tem should be more effective in reducing alcohol intake than one addressing
a single system. To test this hypothesis, we compared the efficacy of low
doses of individual drugs reported to reduce voluntary alcohol drinking to
the efficacy of a mixture of these agents at the same low doses in reducing
alcohol intake in three strains of alcohol-preferring rats (P, HAD, and Fa
wn-Hooded). After establishment of a stable baseline for alcohol intake in
a continuous access paradigm. each rat received separate single i.p. inject
ions of relatively low doses of either naltrexone (2.0 mg/kg), fluoxetine (
1.0 mg/kg), the thyrotropin-releasing hormone analogue TA-0910 (0.2 mg). a
mixture of all three drugs, or the vehicle at 09:30. Each rat received all
treatments, with an inter-injection washout period of at least 3 days. Alco
hol and water intakes were measured at 6 and 24 h, and food intake was meas
ured at 24 h, after the injection. Our results show that individual drugs d
id not significantly affect food, water, or alcohol intake. However, the mi
xture significantly reduced alcohol intake in all three strains, but had no
effect on food intake. Similar results were obtained when the HAD rats rec
eived an oral dose of the individual drugs or the mixture. When P rats were
given an i.p. injection of the mixture for 10 consecutive days, there was
a continued suppressing effect. These findings show that a combination trea
tment designed to target simultaneously serotonergic, dopaminergic, and opi
oidergic systems can reduce alcohol intake, even though the doses of the in
dividual drugs in the mixture are relatively low and ineffective when given
singly.